Author(s):
Barsha Sarma, Tapashi Sutradhar, Kakali Deka, Sonot Deori, Mridul Kumar Borthakur
Email(s):
barshasarma29@gmail.com
DOI:
10.52711/0974-360X.2026.00153 
Address:
Barsha Sarma1*, Tapashi Sutradhar1, Kakali Deka1, Sonot Deori1, Mridul Kumar Borthakur2
1Department of Zoology, Gauhati University, Guwahati, Assam-781014
2PG & Research Department of Zoology, B. Borooah College (Autonomous), Guwahati, Assam-781007, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 3,
Year - 2026
ABSTRACT:
Background: Manihot esculenta Crantz, widely used in traditional medicine, is rich in bioactive compounds with potential antidiabetic properties. This study evaluated the antidiabetic activity of its leaf extracts using in vitro and in vivo models. Methods: Leaves were extracted with methanol. a-Amylase and a-glucosidase inhibition assays were conducted to assess in vitro antidiabetic activity. Streptozotocin-induced diabetic male albino mice were used for in vivo evaluation. Blood glucose and serum lipid profiles were measured using standard methods. Results: The methanolic leaf extract showed IC50 values of 0.367 mg/ml (a-amylase) and 0.351 mg/ml (a-glucosidase). In diabetic mice, the extract significantly reduced blood glucose and improved lipid profiles (except HDL) in a dose-dependent manner. Conclusion: Manihot esculenta leaves exhibit significant antidiabetic activity, supporting their potential as a natural therapeutic or functional food for diabetes management. Further research is needed to isolate active compounds and explore mechanisms of action.
Cite this article:
Barsha Sarma, Tapashi Sutradhar, Kakali Deka, Sonot Deori, Mridul Kumar Borthakur. Assessing the Antidiabetic Properties of Manihot esculenta Crantz leaves through in vitro and in vivo Studies. Research Journal Pharmacy and Technology. 2026;19(3):1080-4. doi: 10.52711/0974-360X.2026.00153
Cite(Electronic):
Barsha Sarma, Tapashi Sutradhar, Kakali Deka, Sonot Deori, Mridul Kumar Borthakur. Assessing the Antidiabetic Properties of Manihot esculenta Crantz leaves through in vitro and in vivo Studies. Research Journal Pharmacy and Technology. 2026;19(3):1080-4. doi: 10.52711/0974-360X.2026.00153 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-3-14
REFERENCES:
1. Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017; 66(2): 241-55. https://doi.org/10.2337/ db16-0806.
2. Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, Chia KS, et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care. 2016; 39(3): 472-85. https://doi.org/10.2337/ dc15-1536.
3. Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation—the two keystones of ischemia/reperfusion injury. Int J Cardiol. 2002; 86(1): 41-59. https://doi.org/10.1016/ S0167-5273(02)00189-4.
4. Aminjan HH, Abtahi SR, Hazrati E, Chamanara M, Jalili M, Paknejad B. Targeting of oxidative stress and inflammation through ROS/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Sci. 2019;232:116607.https:// doi.org/10.1016/j.lfs.2019.116607.
5. Ojah EO, Moronkola DO, Akintunde AAM. α-amylase and α-glucosidase antidiabetic potential of ten essential oils from Calophyllum inophyllum Linn. Iberoam J Med. 2020; 2(4):253- 60. https://doi.org/10.5281/zenodo.3841108.
6. Hedrington MS, Davis SN. Considerations when using alpha glucosidase inhibitors in the treatment of type 2 diabetes. Expert Opin Pharmacother. 2019; 20(18): 2229-35. https://doi.org/10.1080/ 14656566.2019.1672660.
7. Artasensi A, Pedretti A, Vistoli G, Fumagall L. Type 2 diabetes mellitus: a review of multi-target drugs. Molecules. 2020;25(8):1987. https://doi.org/10.3390/molecules25081987.
8. Kirkman MS, Mahmud H, Korytkowski MT. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2018; 47(1): 81-96. https://doi.org/10.1016/j.ecl.2017.10.002.
9. Saifi A, Chauhan R, Dwivedi J. Development of a polyherbal formulation FMST and evaluation for antidiabetic activity in alloxan induced diabetic rats. Asian J. Pharm. Res. 2017; 7(1): 1-7.
10. Madukosiri CH, Amos-Tautua BM. Mineral elements and toxicants insegments of Manihot esculenta grown in Bayelsa state. J Life Phys Sci. 2010; 3:115-118.
11. Fasuyi AO. Nutrient Composition and Processing Effects on cassava leaf (Manihot esculenta Crantz) antinutrient. Pak J of Nutri. 2005; 4(1): 37-42. https://dx.doi.org/10.3923/pjn.2005.37.42.
12. Nwose EU, Onodu BC, Anyasodor AE, Sedowo MO, Okuzor JN, Culas RJ (2017). Ethnopharmacological values of cassava and its potential for diabetes and dyslipidemia management: Knowledge survey and critical review of report. J. Intercult. Ethnopharmacol.; 6(3): 260-266.
13. Tsumbu CN, Dupont GD, Tits M, Angenot L, Franck T, Serteyn D, Mickalad AM. Antioxidant and antiradical activities of Manihot esculenta Crantz (Euphorbiaceae) leaves and other selected tropical green vegetables investigated on lipoperoxidation and phorbol-12-myristate-13-acetate (PMA) activated monocytes. Nutrients. 2011; 3(9): 818-38. https://doi.org/10.3390/nu3090818.
14. Arafa NM, Moawad M, El-Shabrawi HM. Comparison the organic and inorganic solvents effect on phenolic compounds extraction and the activity against breast carcinoma cell lines from callus cultures of Manihot esculenta. Int. J Pharm. Tech. Res. 2016; 9(12): 380-396. https://doi.org/10.13140/RG.2.2.17704.01286.
15. Bahekar S, Kale R. Phytopharmacological aspects of Manihot esculenta Crantz (Cassava). Mint. J of Pharma. & Med. Sc. 2013; 2(1): 2320-3315.
16. Adeyemi OO, Yemitan OK, Afolabi L. Inhibition of chemically induced inflammation and pain by orally and topically administered leaf extract of Manihot esculenta Crantz in rodents. J. Ethnopharma. 2008;119(1, 2): 6-11.
17. Okpuzor J, Oloyede AM. Anti-Inflammatory, Anti-Pyretic and Anti-Diarrhoeal Properties of an Anti-Haemorrhoid Tri-Herbal Pill. Nat. and Sci. 2009; 7(8).
18. Miladiyah I, Dayi F, Desrini S. Analgesic activity of ethanolic extract of Manihot esculenta Crantz leaves in mice. Univ. Med. 2011;30:3-10. http://dx.doi.org/10.18051/UnivMed.
19. Saad R, Appalaswamy L, Khan J, Kazi H, Yusuf E, Asmani F. Phytochemical Screening and Antibacterial Activity of Five Malaysian Medicinal Plants. British J Pharm. Res, 2014;4(17):2019-2032. https://doi.org/10.9734/BJPR/2014/12233.
20. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3): 770-803.https//: doi.org/10.1021/acs.jnatprod.9b01285.
21. Karimov UT, Qing ZH, Aisa HA. Phytochemistry and Pharmacology of the Echinops integrifolius. Res. J. Pharmacognosy and Phytochem. 2018; 10(3): 216-220.
22. Gómez-Vásquez R, Day R, Buschmann H, Randles S, Beeching JR, Cooper RM. Phenylpropanoids, phenylalanine ammonia lyase and peroxidases in elicitor-challenged cassava (Manihot esculenta) suspension cells and leaves. Ann Bot. 2004;94(1):87-97. https://doi.org/10.1093/aob/mch107.
23. Santos CM, Freitas M, Fernandes E. A comprehensive review on xanthone derivatives as α-glucosidase inhibitors. Eur J Med Chem. 2018;157:1460-79. https://doi.org/10.1016/ j. ejmech.2018.07.073.
24. Huang Q, Chai WM, Ma ZY, Ou-Yang C, Wei QM, Song S, et al. Inhibition of α-glucosidase activity and non-enzymatic glycation by tannic acid: Inhibitory activity and molecular mechanism. Int J Biol Macromol. 2019; 141: 358-68. https://doi.org/10.1016/ j.ijbiomac.2019.09.010.
25. Proença C, Ribeiro D, Freitas M, Fernandes E. Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: a review. Crit Rev Food Sci Nutr. 2022; 62(12): 3137-207. https://doi.org/10.1080/ 10408398.2020.1862755.
26. Sabu MC and Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 2002; 81(2): 155-160.
27. Faheem A and Iqbal M (2018). Enzyme (Alpha amylase) Inhibitory activity of Riccinus communis. Org. & Med. Chem IJ; 5(3): 1-4
28. Kumar D, Ghosh R, Pal BC. α-Glucosidase inhibitory terpenoids from Potentilla fulgens and their quantitative estimation by validated HPLC method. J Funct Foods. 2013; 5(3): 1135-41. https://doi.org/10.1016/ j.jff.2013.03.010.
29. OECD. Test no.423: Acute Oral Toxicity-Acute Toxic Class method, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing, Paris. 2002.
30. Smith N, Ferdaoussi M, Lin H and Macdonald PE. Oral Glucose Tolerance Test in Mouse. Protocols. Lo 2020.
31. Funke I, Melzig MF. Traditionally used plants in diabetes therapy: phytotherapeutics as inhibitors of alpha-amylase. Rev Bras Farmacogn. 2006; 16:1-5. https:// doi.org/10.1590/S0102-695X2006000100002.
32. Kifle ZD, Debeb SG, Belayneh YM. In Vitro α-Amylase and α-Glucosidase Inhibitory and Antioxidant Activities of the Crude Extract and Solvent Fractions of Hagenia abyssinica Leaves. Biomed Res Int. 2021: 6652777. doi: 10.1155/2021/6652777.
33. Manivasagan V, Saranya K, Poojashree S, Ankitha K, Niyathi V. In vitro Antioxidant, Antidiabetic and Antibacterial Activities of Orthosiphon diffusus. Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(3): 163-0.
34. Zafar M, Naee I, Hassan NS, Ahmed N, Kaim-Khani Z. Altered liver morphology and enzymes in Streptozotocin induced diabetic rats. Int. J of Morpho. 2009; 27719-725.
35. Ikewuch JC, Ikwuchi CC. Positive moderation of the hematology, plasma biochemistry and ocular indices of oxidative stress in alloxan induced diabetic rats by an aqueous extract of the leaves of Sanseivieria liberica genome and Labroy. Asian Pac. J. Trop. Med. 2012; 27-36.
36. Macharla SP, Goli V, Nath R. Antidiabetic Activity of Bambusa arundinaceae Root Extracts on Alloxan Induced Diabetic Rats. Asian J. Res. Pharm. Sci. 2012; 2(2): 73-75.
37. Formulation and Evaluation of Antidiabetic Herbal Capsules. P. B. Suruse, M. K. Kale, N. J. Duragkar, A. Gundawar. Research J. Pharma. Dosage Forms and Tech. 2011; 4(2): 113-118.
38. Dongare SS, Maske AP, Patil SM, Umbare RP, Mate GS. Antidiabetic Activity of Marsilea quadrifolia linn in Alloxan-Diabetic Rats. Research J. Pharmacognosy and Phytochemistry 2009; 1(1): 15-17.
39. R Sathish, K Natarajan, S Selvakumar. Antidiabetic Activity of Swietenia mahagoni Seed Powder in Alloxan Induced Diabetic Mice. Research J. Pharmacology and Pharmacodynamics. 2010; 2(4): 296-299.
40. Amutha K, Aishwarya S. Evaluation of Antibacterial and Antidiabetic Activity and Phytochemical Analysis of Syzygium cumini (l.) Skeels. Seed. Research J. Pharmacology and Pharmacodynamics. 2010; 2(5): 348-350.
41. Gbenenee TJ, Okoko T, Boisa N. Evaluation of the anti-lipid peroxidative potential of Ficus caprefolia leaf extract using in vitro models. J. Adv. Biol. 2017;16(2):1-8.
42. Gbenenee TJ, Boisa N, Okoko T. Phytochemical Screening and evaluation of antioxidant activity of Ficus caprefolia leaf extract via in vitro models. Int J Biochem Res Rev. 2017;17(2):1-7.
43. Yakubu MT, Akanji MA, Oladiji AT. Alterations in serum lipid profile of male rats by oral administration of Fadogia agresis stem. Res. J. Med. Plant. 2008;2(2):66-73.
44. Pari L, Uma M. Antihyperglycemic activity of Musa sapientum flowers: Effect on Lipid peroxidation in alloxan induced diabetic rats. Phytother. Res. 2000;14(2):136-138.
45. Radhika K, Kumaravel B, Thamizhiniyan V, Subramanian S. Biochemical evaluation of antidiabetic activity of Piper betel leaves extract in alloxan-induced diabetic rats. Asian J. Research Chem. 2013; 6(1):76-82.
46. Salunkhe VR, Bhise SB. Synergistic Effect of Natural Sweetener on Antidiabetic Potential of Madhujeevan churna. Research J. Pharmacognosy and Phytochemistry. 2009; 1(3): 204-208.